MARTINA, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 3.753
AS - Asia 1.582
EU - Europa 1.462
SA - Sud America 382
AF - Africa 127
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.312
Nazione #
US - Stati Uniti d'America 3.691
SG - Singapore 484
VN - Vietnam 369
RU - Federazione Russa 320
BR - Brasile 302
CN - Cina 299
IT - Italia 257
HK - Hong Kong 174
IE - Irlanda 156
SE - Svezia 147
FR - Francia 133
DE - Germania 103
UA - Ucraina 95
GB - Regno Unito 67
CI - Costa d'Avorio 62
IN - India 59
FI - Finlandia 54
TR - Turchia 38
BD - Bangladesh 29
AR - Argentina 27
CA - Canada 27
DK - Danimarca 26
NL - Olanda 26
JP - Giappone 25
MX - Messico 25
PL - Polonia 21
ZA - Sudafrica 21
MA - Marocco 19
KR - Corea 18
IQ - Iraq 16
AT - Austria 15
ES - Italia 15
EC - Ecuador 13
VE - Venezuela 13
BE - Belgio 11
ID - Indonesia 11
PK - Pakistan 11
PH - Filippine 8
CL - Cile 7
CO - Colombia 7
PY - Paraguay 7
UZ - Uzbekistan 6
AU - Australia 5
SA - Arabia Saudita 5
TN - Tunisia 5
CU - Cuba 4
CZ - Repubblica Ceca 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EG - Egitto 3
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
MY - Malesia 3
PE - Perù 3
RO - Romania 3
TH - Thailandia 3
AM - Armenia 2
AZ - Azerbaigian 2
CH - Svizzera 2
ET - Etiopia 2
GE - Georgia 2
IL - Israele 2
LT - Lituania 2
NG - Nigeria 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
NI - Nicaragua 1
OM - Oman 1
PT - Portogallo 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 7.312
Città #
Ashburn 637
Dallas 393
Chandler 367
Des Moines 324
Singapore 305
San Jose 176
Hong Kong 168
Dublin 146
New York 131
Boardman 128
Ho Chi Minh City 118
Fairfield 117
Hanoi 101
Jacksonville 101
The Dalles 79
Los Angeles 69
Beijing 66
Lauterbourg 65
Council Bluffs 63
Abidjan 61
Wilmington 58
Lawrence 53
Princeton 53
Seattle 53
Woodbridge 53
Houston 44
Moscow 44
Munich 41
Cambridge 37
Centro 35
San Mateo 34
São Paulo 26
Turin 25
Buffalo 23
London 23
San Diego 23
Santa Clara 23
Turku 23
Hefei 22
Washington 20
Guangzhou 19
Helsinki 19
Milan 19
Tokyo 19
Warsaw 19
Da Nang 18
Orem 17
Haiphong 15
Columbus 14
Redmond 14
Denver 13
Johannesburg 13
Phoenix 13
Pune 13
Atlanta 12
Chicago 12
Frankfurt am Main 12
Rio de Janeiro 12
Shanghai 12
Ancona 11
Ann Arbor 11
Rome 11
Toronto 11
Baghdad 10
Boston 10
Chennai 10
Stockholm 10
Pesaro 9
Urbisaglia 9
Brussels 8
Curitiba 8
Montreal 8
Wuhan 8
Brasília 7
Brooklyn 7
Mexico City 7
Mumbai 7
Norwalk 7
Vienna 7
Amsterdam 6
Kolkata 6
Bắc Ninh 5
Florence 5
Guarulhos 5
Guayaquil 5
Hải Dương 5
Jiaxing 5
Kazan' 5
Kyiv 5
Maracaibo 5
Poplar 5
Quito 5
San Francisco 5
Thái Nguyên 5
Belo Horizonte 4
Biên Hòa 4
Buenos Aires 4
City of London 4
Creazzo 4
Dhaka 4
Totale 4.890
Nome #
Adalimumab modulates angiogenesis in psoriatic skin 168
Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature 167
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review 167
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review 149
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 147
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 147
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 141
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 141
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 137
Buschke–ollendorff syndrome in a 6-year old patient: Clinical anhistopathological aspects of a rare disease 137
Skin Involvement in SARS-CoV-2 Infection: Case Series 136
Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial 134
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature 132
Activated switched memory B cell clusters in chronic spontaneous urticaria are increased in subjects with long disease duration and relapse upon omalizumab discontinuation: Results of the IL-10-OMZ study 131
"BOTULINUM TOXIN IN DERMATOLOGY: A CLINICAL OVERVIEW" 128
Elastosis perforans serpiginosa: a case successfully treated with intralesional steroids and topical allium cepa-allantoin-pentaglycan gel 127
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 127
Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox? 126
Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know 124
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside 123
Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study 122
Novel therapeutic approaches and targets for treatment of chronic urticaria: New insights and promising targets for a challenging disease 122
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 121
Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach. 121
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 120
Hidradenitis suppurativa: How to treat with BoNT-A 120
Botulinum Toxin Off-Label Use in Dermatology: A Review 119
Primary cutaneous large cell lymphoma CD30+: a case-based review 119
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 119
Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis: An Italian multicentre study 118
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review 118
Photoprotection and photodermatitis: a case 118
Asymptomatic pigmentation of the skin in a child: babywipes, once again 118
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities 117
Safety update of etanercept treatment for moderate to severe plaque psoriasis 116
Topical application of fumaric acid esters improves appearance of nail psoriasis 112
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 110
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 109
Acral Leukoderma: Is It Always Vitiligo? 109
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 105
Psoriasis as an immune-mediated and inflammatory systemic disease: From pathophysiology to novel therapeutic approaches 105
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy 104
Role of small intestinal bacterial overgrowth and helicobacter pylori infection in chronic spontaneous urticaria: a prospective analysis 103
Italian Guidelines in patch testing - Adapted from the European Society of Contact Dermatitis (ESCD) 103
Iperidrosi focale: novità terapeutiche 102
It is never too late to treat chronic spontaneous urticaria with omalizumab: Real-life data from a multicenter observational study focusing on elderly patients 97
Modern electronic devices: An increasingly common cause of skin disorders in consumers 94
How to fight SARS-COV-2 vaccine hesitancy in patients suffering from chronic and immune-mediated skin disease: four general rules 92
A tricky case of contact dermatitis: Simultaneous allergic reaction to topical and oral acyclovir, and scar gel 90
Myroxylon pereirae (balsam of Peru): Still worth testing? 90
COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study 89
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 87
Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage 84
Saliva and Oral Diseases 84
Contact allergy to hydrocortisone 21-acetate in Italy: A SIDAPA multicenter study 84
Pain Control during the Treatment of Primary Palmar Hyperhidrosis with Botulinum Toxin A by a Topical Application of Liposomal Lidocaine: Clinical Effectiveness 81
Saliva proteomics as fluid signature of inflammatory and immune mediated skin diseases 78
Mesenchymal Stem Cells and Psoriasis: Systematic Review 77
Hand eczema in Italian patients referred for patch testing: A retrospective SIDAPA study (2016–2023) 77
Omalizumab in Chronic Urticaria: An Italian Survey. 74
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018–2019 74
Late Patch Test Reaction to Acrylates in 2 Patients: Should We Schedule a Check at Weeks 2 and 3? 72
Infliximab-induced eruptive sebaceous hyperplasia in patient treated for ulcerative colitis: first reported case 63
The pharmacological treatment and management of hyperhidrosis 59
Preliminary experience with abrocitinib in severe atopic dermatitis 59
Translation and pre-validation of the Quality of Life in Hand Eczema Questionnaire (QOLHEQ) in Italian 56
The Challenge Arising from New Knowledge about Immune and Inflammatory Skin Diseases: Where We Are Today and Where We Are Going 56
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens 49
Treatment of Axillary Bromhidrosis with Topical 2% Glycopyrronium Bromide Cream: A Prospective, Non-randomized, Open-label Study 44
Totale 7.449
Categoria #
all - tutte 34.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021140 0 0 0 0 0 0 0 0 0 35 68 37
2021/2022409 8 56 12 2 35 15 9 31 23 12 121 85
2022/20231.180 78 119 63 97 52 419 0 48 204 5 77 18
2023/2024604 86 11 58 66 86 172 10 16 6 20 11 62
2024/20251.241 150 92 22 26 41 30 103 46 308 86 169 168
2025/20263.288 306 211 379 293 399 210 624 290 314 262 0 0
Totale 7.449